Douglas J Opel1,2, Nora Henrikson3, Katherine Lepere4, Rene Hawkes3, Chuan Zhou4,2, John Dunn3, James A Taylor2. 1. Seattle Children's Research Institute, Seattle, Washington; douglas.opel@seattlechildrens.org. 2. Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington; and. 3. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 4. Seattle Children's Research Institute, Seattle, Washington.
Abstract
OBJECTIVE: To evaluate the effect of vaccine hesitancy screening on childhood vaccine uptake. METHODS: We conducted a cluster randomized controlled trial in pediatric primary care clinics in Washington state. Vaccine-hesitant parents (VHPs) with a healthy newborn receiving health supervision at participating clinics were eligible. VHPs were identified by using a 4-item version of the validated Parent Attitudes About Childhood Vaccines Survey (PACV). Before their child's 2- and 6-month health supervision visits, VHPs at intervention clinics completed the 15-item PACV embedded in a survey containing placebo items. Intervention providers received a summary of parents' 15-item PACV responses and interpretation of their PACV score; discretion was given to providers regarding how they acted on this information. VHPs at control clinics completed only the placebo survey items, and their child's provider received a summary of their responses; control providers remained blinded to parent VHP status. Our outcome was child immunization status at 8 months of age expressed as percent of days underimmunized. We compared outcomes in control and intervention participants using t test and linear mixed-effects regression. RESULTS:We enrolled 24 clinics (12 in each arm) and 156 parents (65 in the intervention arm). Parent characteristics were similar across arms except more intervention (versus control) parents had a first-born child (60.9% vs 44%; P = .04). No significant difference in outcome was detected between arms (25.2% [95% confidence interval: 16.0% to 34.5%] vs 19.1% [95% confidence interval: 12.0% to 26.3%] mean days underimmunized in the intervention and control arms, respectively). CONCLUSION:Vaccine hesitancy screening was not significantly associated with days underimmunized.
RCT Entities:
OBJECTIVE: To evaluate the effect of vaccine hesitancy screening on childhood vaccine uptake. METHODS: We conducted a cluster randomized controlled trial in pediatric primary care clinics in Washington state. Vaccine-hesitant parents (VHPs) with a healthy newborn receiving health supervision at participating clinics were eligible. VHPs were identified by using a 4-item version of the validated Parent Attitudes About Childhood Vaccines Survey (PACV). Before their child's 2- and 6-month health supervision visits, VHPs at intervention clinics completed the 15-item PACV embedded in a survey containing placebo items. Intervention providers received a summary of parents' 15-item PACV responses and interpretation of their PACV score; discretion was given to providers regarding how they acted on this information. VHPs at control clinics completed only the placebo survey items, and their child's provider received a summary of their responses; control providers remained blinded to parent VHP status. Our outcome was child immunization status at 8 months of age expressed as percent of days underimmunized. We compared outcomes in control and intervention participants using t test and linear mixed-effects regression. RESULTS: We enrolled 24 clinics (12 in each arm) and 156 parents (65 in the intervention arm). Parent characteristics were similar across arms except more intervention (versus control) parents had a first-born child (60.9% vs 44%; P = .04). No significant difference in outcome was detected between arms (25.2% [95% confidence interval: 16.0% to 34.5%] vs 19.1% [95% confidence interval: 12.0% to 26.3%] mean days underimmunized in the intervention and control arms, respectively). CONCLUSION: Vaccine hesitancy screening was not significantly associated with days underimmunized.
Authors: Douglas J Opel; John Heritage; James A Taylor; Rita Mangione-Smith; Halle Showalter Salas; Victoria Devere; Chuan Zhou; Jeffrey D Robinson Journal: Pediatrics Date: 2013-11-04 Impact factor: 7.124
Authors: Salini Mohanty; Amy Carroll-Scott; Marissa Wheeler; Cecilia Davis-Hayes; Renee Turchi; Kristen Feemster; Michael Yudell; Alison M Buttenheim Journal: Qual Health Res Date: 2018-06-27
Authors: Luke J Matthews; Sarah A Nowak; Courtney C Gidengil; Christine Chen; Joseph M Stubbersfield; Jamshid J Tehrani; Andrew M Parker Journal: Am Anthropol Date: 2022-02-26
Authors: Anne M Butler; Victoria F Grabinski; Gabrielle D Boloker; Jason G Newland; Mary C Politi Journal: Vaccine Date: 2020-05-15 Impact factor: 3.641
Authors: Rachel M Cunningham; Danielle Guffey; Charles G Minard; Douglas J Opel; Julie A Boom Journal: Hum Vaccin Immunother Date: 2021-01-26 Impact factor: 3.452
Authors: C Corti; G Antonarelli; F Scotté; J P Spano; J Barrière; J M Michot; F André; G Curigliano Journal: Ann Oncol Date: 2021-10-28 Impact factor: 32.976